Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer

Condition:   Esophageal Cancer
Intervention:   Drug: nab-paclitaxel group
Sponsor:   Tianjin Medical University Cancer Institute and Hospital
Recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1rsJyu2
via IFTTT